FAK inhibitor(Signet Therapeutics)

N/A

Report date: 2024/05/28 14:25:07
NMEFirst In Class

Base Information

Drug NameFAK inhibitor(Signet Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionFocal adhesion kinase inhibitors
TargetsFocal adhesion kinase
Therapy Area/IndicationsOvarian NeoplasmsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaPreclinical
Originator CompaniesSeeker Shengke (Shenzhen) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSeeker Shengke (Shenzhen) Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsStomach NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A